CpG motifs in bacterial DNA and their immune effects

被引:2077
作者
Krieg, AM [1 ]
机构
[1] Dept Vet Affairs Med Ctr, Iowa City, IA 52246 USA
[2] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[3] Coley Pharmaceut Grp, Wellesley, MA 02481 USA
关键词
D O I
10.1146/annurev.immunol.20.100301.064842
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Unmethylated CpG motifs are prevalent in bacterial but not vertebrate genomic DNAs. Oligodeoxynucleotides (ODN) containing CpG motifs activate host defense mechanisms leading to innate and acquired immune responses. The recognition of CpG motifs requires Toll-like receptor (TLR) 9, which triggers alterations in cellular redox balance and the induction of cell signaling pathways including the mitogen activated protein kinases (MAPKs) and NFkappaB. Cells that express TLR-9, which include plasmacytoid dendritic cells (PDCs) and B cells, produce Th1-like proinflammatory cytokines, interferons, and chemokines. Certain CpG motifs (CpG-A) are especially potent at activating NK cells and inducing IFN-alpha production by PDCs, while other motifs (CpG-B) are especially potent B cell activators. CpG-induced activation of innate immunity protects against lethal challenge with a wide variety of pathogens, and has therapeutic activity in murine models of cancer and allergy. CpG ODN also enhance the development of acquired immune responses for prophylactic and therapeutic vaccination.
引用
收藏
页码:709 / 760
页数:52
相关论文
共 314 条
  • [81] Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA
    Gilkeson, GS
    Ruiz, P
    Pippen, AMM
    Alexander, AL
    Lefkowith, JB
    Pisetsky, DS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1389 - 1397
  • [82] Glover JM, 1997, J PHARMACOL EXP THER, V282, P1173
  • [83] Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion
    Goeckeritz, BE
    Flora, M
    Witherspoon, K
    Vos, Q
    Lees, A
    Dennis, GJ
    Pisetsky, DS
    Klinman, DM
    Snapper, CM
    Mond, JJ
    [J]. INTERNATIONAL IMMUNOLOGY, 1999, 11 (10) : 1693 - 1700
  • [84] Goto Mami, 2000, Microbial and Comparative Genomics, V5, P51, DOI 10.1089/10906590050145267
  • [85] Interleukin-12-and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice
    Gramzinski, RA
    Doolan, DL
    Sedegah, M
    Davis, HL
    Krieg, AM
    Hoffman, SL
    [J]. INFECTION AND IMMUNITY, 2001, 69 (03) : 1643 - 1649
  • [86] ADJUVANTS FOR HUMAN VACCINES - CURRENT STATUS, PROBLEMS AND FUTURE-PROSPECTS
    GUPTA, RK
    SIBER, GR
    [J]. VACCINE, 1995, 13 (14) : 1263 - 1276
  • [87] Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides
    Gursel, I
    Gursel, M
    Ishii, KJ
    Klinman, DM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (06) : 3324 - 3328
  • [88] PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES BIND TO BASIC FIBROBLAST GROWTH-FACTOR, INHIBIT ITS BINDING TO CELL-SURFACE RECEPTORS, AND REMOVE IT FROM LOW-AFFINITY BINDING-SITES OIL EXTRACELLULAR-MATRIX
    GUVAKOVA, MA
    YAKUBOV, LA
    VLODAVSKY, I
    TONKINSON, JL
    STEIN, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2620 - 2627
  • [89] Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells
    Häcker, H
    Mischak, H
    Häcker, G
    Eser, S
    Prenzel, N
    Ullrich, A
    Wagner, H
    [J]. EMBO JOURNAL, 1999, 18 (24) : 6973 - 6982
  • [90] CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
    Häcker, H
    Mischak, H
    Miethke, T
    Liptay, S
    Schmid, R
    Sparwasser, T
    Heeg, K
    Lipford, GB
    Wagner, H
    [J]. EMBO JOURNAL, 1998, 17 (21) : 6230 - 6240